SUPPLEMENT

Q4 2022 — Financial statement information

Q4 2022PDF · 20 pages306 KB
Three months ended
December 31, Year ended
December 31,
2022 2021 2022 2021
Net sales $ 8,079 $ 8,612 $ 34,229 $ 35,355
Operating expenses
Cost of sales 4,585 4,698 19,232 18,795
Selling, general and administrative expenses 2,146 1,824 9,049 7,197
Research, development and related expenses 445 474 1,862 1,994
(Gain) loss on business divestitures — — (2,724) —
Goodwill impairment expense 271 — 271 —
Total operating expenses 7,447 6,996 27,690 27,986
Operating income 632 1,616 6,539 7,369
Other expense (income), net 35 52 147 165
Income before income taxes 597 1,564 6,392 7,204
Provision for income taxes 62 227 612 1,285
Income of consolidated group 535 1,337 5,780 5,919
Income (loss) from unconsolidated subsidiaries, net of taxes 8 3 11 10
Net income including noncontrolling interest 543 1,340 5,791 5,929
Less: Net income (loss) attributable to noncontrolling interest 2 1 14 8
Net income attributable to 3M $ 541 $ 1,339 $ 5,777 $ 5,921
Weighted average 3M common shares outstanding – basic 551.9 574.9 566.0 579.0
Earnings per share attributable to 3M common shareholders – basic $ 0.98 $ 2.33 $ 10.21 $ 10.23
Weighted average 3M common shares outstanding – diluted 552.9 579.9 567.6 585.3
Earnings per share attributable to 3M common shareholders – diluted $ 0.98 $ 2.31 $ 10.18 $ 10.12
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)

-- 1 of 20 --

December 31,
2022 December 31,
2021
ASSETS
Current assets
Cash and cash equivalents $ 3,655 $ 4,564
Marketable securities – current 238 201
Accounts receivable – net 4,532 4,660
Inventories 5,372 4,985
Prepaids 435 654
Other current assets 456 339
Total current assets 14,688 15,403
Property, plant and equipment – net 9,178 9,429
Operating lease right of use assets 829 858
Goodwill and intangible assets – net 17,489 18,774
Other assets 4,271 2,608
Total assets $ 46,455 $ 47,072
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current portion of long-term debt $ 1,938 $ 1,307
Accounts payable 3,183 2,994
Accrued payroll 692 1,020
Accrued income taxes 259 260
Operating lease liabilities – current 261 263
Other current liabilities 3,190 3,191
Total current liabilities 9,523 9,035
Long-term debt 14,001 16,056
Other liabilities 8,161 6,864
Total liabilities 31,685 31,955
Total equity 14,770 15,117
Shares outstanding
December 31, 2022: 549,245,105
December 31, 2021: 571,845,478
Total liabilities and equity $ 46,455 $ 47,072
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)

-- 2 of 20 --

Year ended
December 31,
2022 2021
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 5,591 $ 7,454
Cash flows from investing activities:
Purchases of property, plant and equipment (1,749) (1,603)
Purchases and proceeds from sale or maturities of marketable securities and investments –
net 11 204
Proceeds from sale of businesses, net of cash sold 13 —
Cash payment from Food Safety business split-off, net of divested cash 478 —
Other investing activities 201 82
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (1,046) (1,317)
Cash flows from financing activities:
Change in debt (838) (1,145)
Purchases of treasury stock (1,464) (2,199)
Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 381 639
Dividends paid to shareholders (3,369) (3,420)
Other financing activities (60) (20)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (5,350) (6,145)
Effect of exchange rate changes on cash and cash equivalents (104) (62)
Net increase (decrease) in cash and cash equivalents (909) (70)
Cash and cash equivalents at beginning of year 4,564 4,634
Cash and cash equivalents at end of period $ 3,655 $ 4,564
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)

-- 3 of 20 --

Three months ended December
31, 2021 GAAP $ 490 17.2 % $ 376 17.2 % $ 1,616 18.8 % $ 1,564 $ 227 14.5 % $ 1,339 $ 2.31
Adjustments for special
items:
Net costs for significant
litigation 72 — 104 104 24 80 0.14
Three months ended December
31, 2021 adjusted amounts
(non-GAAP measures) (a) $ 562 19.7 % $ 376 17.2 % $ 1,720 20.0 % $ 1,668 $ 251 15.1 % $ 1,419 $ 2.45
Three months ended December
31, 2022 GAAP $ 618 22.6 % $ (434) (21.1) % $ 632 7.8 % $ 597 $ 62 10.5 % $ 541 $ 0.98 (58) %
Adjustments for special
items:
Net costs for significant
litigation (7) — 58 58 20 38 0.07
Divestiture costs — — 54 54 11 43 0.08
PFAS manufacturing exit
costs — 800 800 800 162 638 1.15
Total special items (7) 800 912 912 193 719 1.30
Three months ended December
31, 2022 adjusted amounts
(non-GAAP measures) (a) $ 611 22.4 % $ 366 17.8 % $ 1,544 19.1 % $ 1,509 $ 255 16.9 % $ 1,260 $ 2.28 (7) %
Year ended December 31, 2021
GAAP 2,466 20.6 % $ 1,880 20.3 % $ 7,369 20.8 % $ 7,204 $ 1,285 17.8 % $ 5,921 $ 10.12
Adjustments for special
items:
Net costs for significant
litigation 249 — 463 463 104 359 0.61
Year ended December 31, 2021
adjusted amounts (non-GAAP
measures) (a) $ 2,715 22.7 % $ 1,880 20.3 % $ 7,832 22.2 % $ 7,667 $ 1,389 18.1 % $ 6,280 $ 10.73
Year ended December 31, 2022
GAAP 1,199 10.3 % $ 1,012 11.4 % $ 6,539 19.1 % $ 6,392 $ 612 9.6 % $ 5,777 $ 10.18 1 %
Adjustments for special
items:
Net costs for significant
litigation 1,414 — 2,291 2,291 476 1,815 3.20
Divestiture costs — — 60 60 13 47 0.08
Gain on business
divestitures — — (2,724) (2,724) (39) (2,685) (4.73)
Divestiture-related
restructuring actions — — 41 41 9 32 0.05
Russia exit charges — — 109 109 (2) 111 0.20
PFAS manufacturing exit
costs — 800 800 800 162 638 1.12
Total special items 1,414 800 577 577 619 (42) (0.08)
Year ended December 31, 2022
adjusted amounts (non-GAAP
measures) (a) $ 2,613 22.5 % $ 1,812 20.4 % $ 7,116 20.8 % $ 6,969 $ 1,231 17.7 % $ 5,735 $ 10.10 (6) %
Operating Income (Loss) Net
Income
Attribut
able to
3M
Earnings
per
diluted
share
percent
change
(Dollars in millions, except per share
amounts)
Safety
and
Industrial
Safety
and
Industrial
Margin
Transport
ation and
Electronics
Transport
ation and
Electronics
Margin
Total
Company
Total
Company
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Effective
Tax
Rate
Earnings
per
Diluted
Share
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)

-- 4 of 20 --

(a) In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that
adjust for the impacts of special items. Special items for the periods presented include the items described in the
section entitled “Description of Special Items”. Operating income (loss), segment operating income (loss), income
before taxes, net income, earnings per share, and the effective tax rate are all measures for which 3M provides the
reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with,
nor are they a substitute for, GAAP measures. While the Company includes certain items in its measure of segment
operating performance, it also considers these non-GAAP measures in evaluating and managing its operations. The
Company believes that discussion of results adjusted for special items is useful to investors in understanding
underlying business performance, while also providing additional transparency to the special items. Special items
impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net
costs for significant litigation and PFAS manufacturing exit costs in the “Description of Special Items” section. The
determination of these items may not be comparable to similarly titled measures used by other companies.
In the first quarter of 2022, the Company changed the extent of matters and charges/benefits it includes within special
items with respect to net costs for significant litigation. Previously, 3M included net costs, when significant, associated
with changes in accrued liabilities related to respirator mask/asbestos litigation and PFAS-related other environmental
matters, along with the associated tax impacts. The non-GAAP measure changes involved including net costs for
litigation related to 3M's Combat Arms Earplugs, expanding net costs to include external legal fees and insurance
recoveries associated with the applicable matters in addition to changes in accrued liabilities, and to include all such
net costs for the applicable matters, not just when considered significant. The information provided herein reflects the
impacts of these changes for all periods presented.
Three months ended
December 31, Year ended
December 31,
Major GAAP Cash Flow Categories (dollars in millions) 2022 2021 2022 2021
Net cash provided by (used in) operating activities $ 1,922 $ 2,005 $ 5,591 $ 7,454
Net cash provided by (used in) investing activities (388) 115 (1,046) (1,317)
Net cash provided by (used in) financing activities (1,315) (2,412) (5,350) (6,145)
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 5 of 20 --

Three months ended
December 31, Year ended
December 31,
Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021
Net cash provided by (used in) operating activities $ 1,922 $ 2,005 $ 5,591 $ 7,454
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts 178 158 716 362
Divestiture costs after-tax payment impacts 6 — 8 —
Divestiture gains - closing cost after tax payment impacts 27 — 27 —
Divestiture-related restructuring after-tax payment impacts 24 1 28 6
Russia exit charges after-tax payment impacts — — 2 —
TCJA transition tax payment — — 68 77
Total adjustments for special items 235 159 849 445
Adjusted net cash provided by (used in) operating activities (b) 2,157 2,164 6,440 7,899
Purchases of property, plant and equipment (506) (556) (1,749) (1,603)
Adjusted free cash flow (b) $ 1,651 $ 1,608 $ 4,691 $ 6,296
Net income attributable to 3M $ 541 $ 1,339 $ 5,777 $ 5,921
Adjustments for special items:
Net costs for significant litigation 38 80 1,815 359
Divestiture costs 43 — 47 —
(Gain) loss on business divestitures — — (2,685) —
Divestiture-related restructuring actions — — 32 —
Russia exit charges — — 111 —
PFAS manufacturing exit costs 638 — 638 —
Total special items 719 80 (42) 359
Adjusted net income attributable to 3M (a) $ 1,260 $ 1,419 $ 5,735 $ 6,280
Adjusted free cash flow conversion (b) 131 % 113 % 82 % 100 %
(b) Adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow
conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash
flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by
other companies. The Company defines adjusted net cash provided by (used in) operating activities as net cash
provided by operating activities, adjusted for special items. The Company defines adjusted free cash flow as adjusted
net cash provided by (used in) operating activities less purchases of property, plant and equipment. Cash payments
associated with special items in the determination of adjusted net cash provided by (used in) operating activities are
reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be
inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company
defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M,
adjusted for special items. Special items for the periods presented include the items described in section entitled
“Description of Special Items”. The Company believes adjusted net cash provided by (used in) operating activities,
adjusted free cash flow and adjusted free cash flow conversion are meaningful to investors as they are useful measures
of performance and the Company uses these measures as an indication of the strength of the Company and its ability to
generate cash.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 6 of 20 --

Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP
measure) (c)
Three months ended
December 31, Year ended
December 31, Three months ended
December 31, Year ended
December 31,
(Dollars in millions) 2022 2021 2022 2021 2022 2021 2022 2021
Safety and Industrial $ 752 $ 715 $ 3,179 $ 3,308 27.5 % 25.1 % 27.4 % 27.6 %
Transportation and Electronics 474 487 2,222 2,299 23.0 % 22.3 % 25.0 % 24.8 %
Health Care 583 674 2,438 2,673 28.5 % 30.7 % 29.0 % 31.1 %
Consumer 261 334 1,142 1,309 20.9 % 24.0 % 21.5 % 23.7 %
Corporate and Unallocated (66) 17 (34) 158
Total Company $ 2,004 $ 2,227 $ 8,947 $ 9,747 24.8 % 25.9 % 26.1 % 27.6 %
Three months ended
December 31, Year ended
December 31,
Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021
Net sales $ 8,079 $ 8,612 $ 34,229 $ 35,355
Net income attributable to 3M 541 1,339 5,777 5,921
Add/(subtract):
Net income/(loss) attributable to noncontrolling interest 2 1 14 8
(Income)/loss from unconsolidated subsidiaries, net of taxes (8) (3) (11) (10)
Provision for income taxes 62 227 612 1,285
Other expense/(income):
Interest (Income)/expense 84 110 395 462
Pension & OPEB non-service cost (benefit) (49) (58) (248) (297)
Depreciation and amortization expense 460 507 1,831 1,915
Adjustments for special items:
Net costs for significant litigation 58 104 2,291 463
Divestiture costs 54 — 60 —
(Gain) loss on business divestitures — — (2,724) —
Divestiture-related restructuring actions — — 41 —
Russia exit charges — — 109 —
PFAS manufacturing exit costs 800 — 800 —
Total special items 912 104 577 463
Adjusted EBITDA (c) $ 2,004 $ 2,227 $ 8,947 $ 9,747
Adjusted EBITDA margin (c) 24.8 % 25.9 % 26.1 % 27.6 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 7 of 20 --

Adjusted EBITDA (non-GAAP measure)
Three months ended December 31, 2022 (dollars in
millions) Safety and
Industrial
Transportation
and
Electronics Health
Care Consumer
Corporate
and
Unallocated Total
Company
Net sales $ 2,735 $ 2,055 $ 2,042 $ 1,246 $ 1 $ 8,079
Business segment operating income (loss)
(measure of segment operating performance) $ 618 $ (434) $ 421 $ 224 $ (197) $ 632
Add/(subtract):
Depreciation and amortization 141 108 162 37 12 460
Adjustments for special items:
Net costs for significant litigation (7) — — — 65 58
Divestiture costs — — — — 54 54
(Gain) loss on business divestitures — — — — — —
PFAS manufacturing exit costs — 800 — — — 800
Total special items $ (7) 800 — — $ 119 912
Adjusted EBITDA (non-GAAP measure) (c) $ 752 $ 474 $ 583 $ 261 $ (66) $ 2,004
Adjusted EBITDA margin (non-GAAP
measure) (c) 27.5 % 23.0 % 28.5 % 20.9 % 24.8 %
Adjusted EBITDA (non-GAAP measure)
Three months ended December 31, 2021 (dollars in
millions) Safety and
Industrial
Transportation
and
Electronics Health
Care Consumer
Corporate
and
Unallocated Total
Company
Net sales $ 2,848 $ 2,184 $ 2,190 $ 1,390 $ — $ 8,612
Business segment operating income (measure of
segment operating performance) $ 490 $ 376 $ 515 $ 295 $ (60) $ 1,616
Add/(subtract):
Depreciation and amortization 153 111 159 39 45 507
Adjustments for special items:
Net costs for significant litigation 72 — — — 32 104
Total special items 72 — — — 32 104
Adjusted EBITDA (non-GAAP measure) (c) $ 715 $ 487 $ 674 $ 334 $ 17 $ 2,227
Adjusted EBITDA margin (non-GAAP
measure) (c) 25.1 % 22.3 % 30.7 % 24.0 % 25.9 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 8 of 20 --

Adjusted EBITDA (non-GAAP measure)
Year ended December 31, 2022 (dollars in millions) Safety and
Industrial
Transportation
and
Electronics Health
Care Consumer
Corporate
and
Unallocated Total
Company
Net sales $ 11,604 $ 8,902 $ 8,421 $ 5,298 $ 4 $ 34,229
Business segment operating income (loss)
(measure of segment operating performance) $ 1,199 $ 1,012 $ 1,815 $ 994 $ 1,519 $ 6,539
Add/(subtract):
Depreciation and amortization 566 410 623 148 84 1,831
Adjustments for special items:
Net costs for significant litigation 1,414 — — — 877 2,291
Divestiture costs — — — — 60 60
Gain on business divestitures — — — — (2,724) (2,724)
Divestiture-related restructuring actions — — — — 41 41
Russia exit charges — — — — 109 109
PFAS manufacturing exit costs — 800 — — — 800
Total special items 1,414 800 — — (1,637) 577
Adjusted EBITDA (non-GAAP measure) (c) $ 3,179 $ 2,222 $ 2,438 $ 1,142 $ (34) $ 8,947
Adjusted EBITDA margin (non-GAAP
measure) (c) 27.4 % 25.0 % 29.0 % 21.5 % 26.1 %
Adjusted EBITDA (non-GAAP measure)
Year ended December 31, 2021 (dollars in millions) Safety and
Industrial
Transportation
and
Electronics Health
Care Consumer
Corporate
and
Unallocated Total
Company
Net sales $ 11,981 $ 9,262 $ 8,597 $ 5,513 $ 2 $ 35,355
Business segment operating income (measure of
segment operating performance) $ 2,466 $ 1,880 $ 2,037 $ 1,162 $ (176) $ 7,369
Add/(subtract):
Depreciation and amortization 593 419 636 147 120 1,915
Adjustments for special items:
Net costs for significant litigation 249 — — — 214 463
Total special items 249 — — — 214 $ 463
Adjusted EBITDA (non-GAAP measure) (c) $ 3,308 $ 2,299 $ 2,673 $ 1,309 $ 158 $ 9,747
Adjusted EBITDA margin (non-GAAP
measure) (c) 27.6 % 24.8 % 31.1 % 23.7 % 27.6 %
(c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and
adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S.
GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines
adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling
interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income),
depreciation and amortization expense, and special items. For business segments, the Company defines adjusted
EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for
depreciation and amortization expense and special items. The Company defines adjusted EBITDA margin as adjusted
EBITDA divided by net sales. Special items for the periods presented include the items described in the section
entitled “Description of Special Items”. The Company considers these non-GAAP measures in evaluating and
managing the Company’s operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are
meaningful to investors as they provide useful analyses of ongoing underlying operating trends.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 9 of 20 --

Net Debt (non-GAAP measure) December 31, 2022 December 31, 2021
Total debt $ 15,939 $ 17,363
Less: Cash, cash equivalents and marketable securities 3,916 4,792
Net debt (d) $ 12,023 $ 12,571
(d) Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by
other companies. The Company defines net debt as total debt less the total of cash, cash equivalents and current and
long-term marketable securities. 3M believes net debt is meaningful to investors as 3M considers net debt and its
components to be an important indicator of liquidity and a guiding measure of capital structure strategy.
Description of Special Items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters.
Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with
the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs
related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/
asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy
period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as
corporate special items in Corporate and Unallocated. In the fourth quarter of 2022 and 2021, 3M made payments of
approximately $226 million and $200 million, respectively, related to net costs for significant litigation. In the full year
of 2022 and 2021, 3M made payments of approximately $907 million and $458 million, respectively, related to net
costs for significant litigation.
Divestiture costs:
• These include costs related to separating and divesting substantially an entire business segment of 3M following public
announcement of its intended divestiture. In the fourth quarter and full year of 2022, 3M made payments of
approximately $8 million and $11 million, respectively, associated with divestiture costs.
Gain/loss on sale of businesses divestitures:
• In 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of
its Food Safety business with Neogen Corporation. In the fourth quarter and full year of 2022, 3M made payments of
approximately $34 million related to closing costs of the transaction that were part of the determination of the gain
thereon.
Divestiture-related restructuring actions:
• In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed
to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude
of amounts previously allocated to the divested business. In the fourth quarter of 2022 and 2021, 3M made payments
of approximately $29 million and $1 million, respectively, associated with divestiture-related restructuring actions. In
the full year of 2022 and 2021, 3M made payments of approximately $34 million and $8 million, respectively,
associated with divestiture-related restructuring actions.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 10 of 20 --

Russia exit charges:
• In 2022, 3M recorded a charge primarily related to impairment of net assets in Russia in connection with
management’s committed exit and disposal plan. In the fourth quarter and full year of 2022, 3M made payments of
approximately $1 million and $3 million, respectively, related to Russia exit charges.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA)
• In the full year of 2022 and 2021, 3M made payments of approximately $68 million and $77 million, related to the
transition tax expense incurred as a result of the 2017 enactment of the TCJA.
PFAS manufacturing exit costs:
• These costs relate to 3M's December 2022 commitment to a plan to exit PFAS manufacturing by the end of 2025.
Charges for the applicable period relate to asset impairments. These charges were reflected within the Transportation
and Electronics business segment.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)

-- 11 of 20 --

Three months ended December 31, 2022
Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle
East and Africa Worldwide
Organic sales 1.4 % (2.6) % 2.0 % 0.4 %
Divestitures (1.6) (1.1) (2.2) (1.6)
Translation (0.4) (9.5) (10.7) (5.0)
Total sales change (0.6) % (13.2) % (10.9) % (6.2) %
Year ended December 31, 2022
Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle
East and Africa Worldwide
Organic sales 2.6 % 0.3 % (0.6) % 1.2 %
Divestitures (0.6) (0.4) (0.6) (0.5)
Translation (0.3) (6.5) (9.8) (3.9)
Total sales change 1.7 % (6.6) % (11.0) % (3.2) %
Three months ended December 31, 2022
Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales
change
Safety and Industrial 1.3 % — % — % (5.3) % (4.0) %
Transportation and Electronics 1.4 — (1.1) (6.2) (5.9)
Health Care 1.9 — (4.1) (4.5) (6.7)
Consumer (5.7) — (1.6) (3.1) (10.4)
Total Company 0.4 — (1.6) (5.0) (6.2)
Year ended December 31, 2022
Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales
change
Safety and Industrial 1.0 % — % — % (4.2) % (3.2) %
Transportation and Electronics 1.2 — (0.5) (4.6) (3.9)
Health Care 3.2 — (1.4) (3.8) (2.0)
Consumer (0.9) — (0.4) (2.6) (3.9)
Total Company 1.2 — (0.5) (3.9) (3.2)
(e) Total sales change is calculated based on reported sales results. The components of sales change include organic local-
currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume
impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture
impacts are measured separately for the first 12 months post-transaction.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS (e)
(Unaudited)

-- 12 of 20 --

3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating
income and income before taxes. Business segment operating income excludes certain expenses and income that are not
allocated to business segments (as described below in “Corporate and Unallocated”).
Effective in the first quarter of 2022, the measure of segment operating performance used by 3M’s chief operating decision
maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income)
was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance
and allocates resources for the Company’s business segments. The changes included the items described below. The financial
information presented herein reflects the impact of these business segment reporting changes for all periods presented.
Eliminating inclusion of dual credit in measure of segment operating performance
3M business segment operating performance measures were updated to no longer include dual credit to business segments
for certain sales and related operating income. Management previously evaluated its business segments based on net sales
and operating income performance, including dual credit reporting. 3M reflected additional (“dual”) credit to another
business segment when the customer account activity (“sales district”) with respect to the particular product sold to the
external customer was provided by a different business segment. For example, privacy screen protection products are
primarily sold by the Display Materials and Systems Division within the Transportation and Electronics business segment;
however, certain sales districts within the Consumer business segment provide the customer account activity for sales of
the product to particular customers. In this example, the non-primary selling segment (Consumer) previously would also
have received credit for the associated net sales initiated through its sales district and the related approximate operating
income. The offset to the dual credit business segment reporting was reflected as a reconciling item entitled “Elimination of
Dual Credit,” such that sales and operating income in total were unchanged.
Reflecting certain litigation-related costs in the Safety and Industrial segment's operating performance measure
3M's business segment operating performance measure with respect to its Safety and Industrial business segment was
updated relative to litigation-related costs for non-Aearo and Aearo respirator respirator mask/asbestos litigation matters.
Previously, 3M included these costs, when significant, as a special item within Corporate and Unallocated. 3M changed to
include all litigation-related costs associated with respirator mask/asbestos litigation matters (along with other Safety and
Industrial matters already included therein, such as those related to Combat Arms Earplugs) within the Safety and
Industrial business segment. Note, however, that prospectively during the Aearo chapter 11 bankruptcy period (which
began in July 2022) net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/
asbestos matters are reflected in Corporate and Unallocated.
BUSINESS SEGMENT INFORMATION Three months ended
December 31, Year ended
December 31,	NET SALES
(Millions) 2022 2021 2022 2021
Safety and Industrial $ 2,735 $ 2,848 $ 11,604 $ 11,981
Transportation and Electronics 2,055 2,184 8,902 9,262
Health Care 2,042 2,190 8,421 8,597
Consumer 1,246 1,390 5,298 5,513
Corporate and Unallocated 1 — 4 2
Total Company $ 8,079 $ 8,612 $ 34,229 $ 35,355
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)

-- 13 of 20 --

BUSINESS SEGMENT INFORMATION Three months ended
December 31, Year ended
December 31,	OPERATING INCOME (LOSS)
(Millions) 2022 2021 2022 2021
Safety and Industrial $ 618 $ 490 $ 1,199 $ 2,466
Transportation and Electronics (434) 376 1,012 1,880
Health Care 421 515 1,815 2,037
Consumer 224 295 994 1,162
Total business segment operating income (loss) 829 1,676 5,020 7,545
Corporate and Unallocated
Corporate special items:
Net costs for significant litigation (65) (32) (877) (214)
Divestiture costs (54) — (60) —
(Gain) loss on business divestitures — — 2,724 —
Divestiture-related restructuring actions — — (41) —
Russia exit charges — — (109) —
Total corporate special items (119) (32) 1,637 (214)
Other corporate expense - net (78) (28) (118) 38
Total Corporate and Unallocated (197) (60) 1,519 (176)
Total Company operating income 632 1,616 6,539 7,369
Other expense/(income), net 35 52 147 165
Income before income taxes $ 597 $ 1,564 $ 6,392 $ 7,204
Corporate and Unallocated
Corporate and Unallocated operating income includes “corporate special items” and “other corporate expense-net”. Corporate
special items include net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/
asbestos matters during the chapter 11 bankruptcy period (which began in July 2022) and with PFAS-related other
environmental matters. Corporate special items also include divestiture costs, gain/loss on business divestitures, divestiture-
related restructuring costs, and Russia exit costs. Divestiture costs include costs related to separating and divesting substantially
an entire business segment of 3M following public announcement of its intended divestiture. Other corporate expense-net
includes items such as net costs related to limited unallocated corporate staff and centrally managed material resource centers of
expertise costs, corporate philanthropic activity, and other net costs that 3M may choose not to allocate directly to its business
segments. Other corporate expense-net also includes costs and income from transition supply, manufacturing, and service
arrangements with Neogen Corporation following the 2022 split-off of 3M's Food Safety business and with the acquirer of the
former Drug Delivery business following its 2020 divestiture. Items classified as revenue from this activity are included in
Corporate and Unallocated net sales. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject
to fluctuation on a quarterly and annual basis.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)

-- 14 of 20 --

Beginning in 2023, 3M is changing certain of its non-GAAP measures. As a result, 3M’s 2023 outlook expectations herein
reflect measures on that basis. Relevant 2023 non-GAAP measure changes include:
• Adjusting for the results of manufactured PFAS products in arriving at results, adjusted for special items — In the
fourth quarter of 2022, 3M included an adjustment for PFAS manufacturing exit costs. The non-GAAP measure
change involves expanding the extent of adjustment to include the sales and estimates of income (including exit costs)
and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025.
The discussion and tables below provides relevant 2023 outlook expectation non-GAAP measures and prior period non-GAAP
measure information on this new basis.
Full Year 2023 Forecast
2023 adjusted earnings per share — new outlook basis (non-GAAP measure)* (f) $8.50 to $9.00
2023 adjusted effective tax rate — new outlook basis (non-GAAP measure)* (f) 18 % to 19 %
* 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial
measures and, therefore, does not provide them on a forward-looking basis reflecting these items. These include special
items on a 2023 outlook basis such as net costs for significant litigation; projected divestiture gains; divestiture costs;
divestiture-related restructuring; and net sales and estimates of income and associated activity of exited manufactured
PFAS products. This is due to limitations in predicting with reasonable certainty items such as the timing and ultimate
outcome of significant litigation, certain conditions outside of 3M’s control regarding divestitures, the meaningful amount
and timing of costs involved over the duration of an announced segment-sized divestiture, the timing of customer re-
sourcing of product as 3M winds down PFAS manufacturing, and numerous other conditions outside of 3M’s control. 3M
believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For
these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M
does not include the impact of potentially-divested or acquired businesses on expected operations in the forecasted outlook
guidance it provides until close of a transaction. Information with respect to special items on a 2023 outlook basis for
certain relevant historical periods is included herein in this “Supplemental Financial Information Non-GAAP Measures —
New Outlook Basis” section.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - NEW OUTLOOK BASIS
(Unaudited)

-- 15 of 20 --

(Dollars in millions, except per share amounts) Sales Sales
Change
Income
Before
Taxes
Provision
for
Income
Taxes Effective
tax rate
Net Income
Attributabl
e to 3M
Earnings
per Diluted
Share
Year ended December 31, 2021 GAAP $ 35,355 $ 7,204 $ 1,285 17.8 % $ 5,921 10.12
Adjustments for special items — new
outlook basis:
Net costs for significant litigation $ 463 $ 104 $ 359 $ 0.61
Manufactured PFAS products (1,258) (135) (29) (106) (0.18)
Total special items — new outlook
basis (1,258) 328 75 253 0.43
Year ended December 31, 2021
adjusted amounts — new outlook basis
(non-GAAP measures) (f) $ 34,097 $ 7,532 $ 1,360 18.1 % $ 6,174 10.55
Year ended December 31, 2022 GAAP $ 34,229 $ 6,392 $ 612 9.6 % $ 5,777 10.18
Adjustments for special items — new
outlook basis:
Net costs for significant litigation 2,291 476 1,815 3.20
Divestiture costs 60 13 47 0.08
Gain on business divestitures (2,724) (39) (2,685) (4.73)
Divestiture-related restructuring
actions 41 9 32 0.05
Russia exit charges 109 (2) 111 0.20
Manufactured PFAS products (1,351) 631 121 510 0.90
Total special items — new outlook
basis (1,351) 408 — 578 (170) (0.30)
Year ended December 31, 2022
adjusted amounts — new outlook basis
(non-GAAP measures) (f) $ 32,878 (3.6) % $ 6,800 $ 1,190 17.5 % $ 5,607 9.88
(f) In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that
adjust for the impacts of special items as defined on a 2023 outlook basis. Special items on a 2023 outlook basis for
the periods presented include the items described in the section entitled “Description of Special Items — New Outlook
Basis”. Net sales (and sales change), income before taxes, the effective tax rate, net income, and earnings per share, are
all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items on a 2023
outlook basis. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. The
Company considers these non-GAAP measures in evaluating and managing its operations. The Company believes that
discussion of results adjusted for special items on a 2023 outlook basis is useful to investors in understanding
underlying business performance including in relation to 2023 outlook, while also providing additional transparency to
the special items. The determination of these items may not be comparable to similarly titled measures used by other
companies.
Year ended
December 31,
Major GAAP Cash Flow Categories (dollars in millions) 2022 2021
Net cash provided by (used in) operating activities $ 5,591 $ 7,454
Net cash provided by (used in) investing activities (1,046) (1,317)
Net cash provided by (used in) financing activities (5,350) (6,145)
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED)
(Unaudited)

-- 16 of 20 --

(Dollars in billions) Full Year 2023 Forecast
Net cash provided by (used in) operating activities* $5.8 to $6.3
Adjustments for special items — new outlook basis* —
Adjusted net cash provided by (used in) Operating activities — new outlook basis* $5.8 to $6.3
Purchase of property, plant and equipment (PPE) ($1.5 to $1.8)
Manufactured PFAS products impact — removing related purchases of PPE ~$0.2
Adjusted free cash flow — new outlook basis* (g) $4.2 to $5.0
Net income attributable to 3M* $4.7 to $5.0
Adjustments for special items — new outlook basis* —
Adjusted net income attributable to 3M — new outlook basis* (f) $4.7 to $5.0
Adjusted free cash flow conversion — new outlook basis* (g) 90% to 100%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED)
(Unaudited)

-- 17 of 20 --

Year ended
December 31,
Adjusted Free Cash Flow — new outlook basis (non-GAAP measure)
(dollars in millions) 2022 2021
Net cash provided by (used in) operating activities $ 5,591 $ 7,454
Adjustments for special items — new outlook basis:
Net costs for significant litigation after-tax payment impacts 716 362
Divestiture costs after-tax payment impacts 8 —
Divestiture gains - closing cost after tax payment impacts 27 —
Divestiture-related restructuring after-tax payment impacts 28 6
Russia exit charges after-tax payment impacts 2 —
TCJA transition tax payment 68 77
Manufactured PFAS products impact (36) (166)
Total adjustments for special items — new outlook basis 813 279
Adjusted net cash provided by (used in) operating activities — new outlook basis (g) 6,404 7,733
Purchases of property, plant and equipment (PPE) (1,749) (1,603)
Manufactured PFAS products impact — removing related purchases of PPE 175 124
Adjusted free cash flow — new outlook basis (g) $ 4,830 $ 6,254
Net income attributable to 3M $ 5,777 $ 5,921
Adjustments for special items — new outlook basis:
Net costs for significant litigation 1,815 359
Divestiture costs 47 —
(Gain) loss on business divestitures (2,685) —
Divestiture-related restructuring actions 32 —
Russia exit charges 111 —
Manufactured PFAS products 510 (106)
Total special items — new outlook basis (170) 253
Adjusted net income attributable to 3M — new outlook basis (f) $ 5,607 $ 6,174
Adjusted free cash flow conversion — new outlook basis (g) 86 % 101 %
(g) Adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow
conversion all on a 2023 outlook basis are not defined under U.S. GAAP. Therefore, they should not be considered a
substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to
similarly titled measures used by other companies. The Company defines adjusted net cash provided by (used in)
operating activities — new outlook basis as net cash provided by operating activities, adjusted for special items on a
2023 outlook basis. The Company defines adjusted free cash flow — new outlook basis as adjusted net cash provided
by (used in) operating activities — new outlook basis less purchases of property, plant and equipment (PPE) adjusted
for the estimated impact of such purchases associated with manufactured PFAS products activity. Cash payments
associated with special items in the determination of adjusted net cash provided by (used in) operating activities —
new outlook basis are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of
payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary
expenditures. The Company defines adjusted free cash flow conversion — new outlook basis as adjusted free cash
flow — new outlook basis divided by net income attributable to 3M, adjusted for special items on a 2023 outlook
basis. Special items on a 2023 outlook basis for the periods presented include the items described in the section
entitled “Description of Special Items — New Outlook Basis”. The Company believes adjusted net cash provided by
(used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion all on a 2023 outlook
basis are meaningful to investors as they are useful measures of performance and the Company uses these measures as
an indication of the strength of the Company and its ability to generate cash.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED)
(Unaudited)

-- 18 of 20 --

Full-Year 2023 Forecast
Worldwide Sales Change (e) Organic sales Acquisitions Divestitures Translation Total sales change
Total Company* (3)% to flat % — % (1)% (2)% to (1)% (6)% to (2)%
Remove manufactured PFAS
products impact* — % — % — % — % — %
Adjusted total Company — new
outlook basis (non-GAAP
measures)* (f) (3)% to flat % (1)% (2)% to (1)% (6)% to (2)%
Year ended December 31, 2022
Worldwide Sales Change (e) Organic sales Acquisitions Divestitures Translation Total sales
change
Total Company 1.2 % — % (0.5) % (3.9) % (3.2) %
Remove manufactured PFAS products impact (0.4) % — % — % — % (0.4) %
Adjusted total Company — new outlook basis (non-
GAAP measures) (f) 0.8 % (0.5) % (3.9) % (3.6) %
Description of Special Items — New Outlook Basis:
In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides relevant non-GAAP measures that
adjust for the impacts of special items as defined on a 2023 outlook basis. Relevant special items on a 2023 outlook basis for
the periods presented include the items described below. These items align with those included in the section “Supplemental
Financial Information — Non-GAAP Measures, Description of Special Items” which is largely repeated below, with the
exception of the expansion of the extent of adjustment relative to PFAS manufactured products to include the sales and
estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit
by the end of 2025.
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters.
Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with
the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs
related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/
asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy
period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as
corporate special items in Corporate and Unallocated. In 2022 and 2021, 3M made payments of approximately $907
million and $458 million, respectively, related to net costs for significant litigation.
Divestiture costs:
• These include costs related to separating and divesting substantially an entire business segment of 3M following public
announcement of its intended divestiture. In the 2022, 3M made payments of approximately $11 million associated
with divestiture costs.
Gain/loss on sale of businesses divestitures:
• In 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of
its Food Safety business with Neogen Corporation. In 2022, 3M made payments of approximately $34 million related
to closing costs of the transaction that were part of the determination of the gain thereon.
Divestiture-related restructuring actions:
• In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed
to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED)
(Unaudited)

-- 19 of 20 --

of amounts previously allocated to the divested business. In 2022 and 2021, 3M made payments of approximately
$34 million and $8 million, respectively, associated with divestiture-related restructuring actions.
Russia exit charges:
• In 2022, 3M recorded a charge primarily related to impairment of net assets in Russia in connection with
management’s committed exit and disposal plan. In 2022, 3M made payments of approximately $3 million related to
Russia exit charges.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA)
• In 2022 and 2021, 3M made payments of approximately $68 million and $77 million, related to the transition tax
expense incurred as a result of the 2017 enactment of the TCJA.
Manufactured PFAS products:
• These amounts relate to sales and estimates of income and associated activity regarding manufactured PFAS products
that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment.
Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the
non-service cost components of portion defined benefit plan net periodic benefit costs. Relative to the impact of the
activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on
estimates of associated income, depreciation/amortization, and certain changes in working capital.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED)
(Unaudited)

-- 20 of 20 --